Prime Medicine Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Prime Medicine Inc
Access all reports
Prime Medicine is a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies to address the widest spectrum of diseases by deploying its versatile, precise, effective and broad next generation gene editing technology, Prime Editing. Designed to make only the right edit at the right position within a gene, the Company’s Prime Editing technology has broad therapeutic applications and is capable of repairing approximately 90 percent of known disease-causing mutations across many organisms, organs, and cell types. Prime Medicine has purposefully built a diversified portfolio organized around four strategic indication categories, with each set of indications chosen to deliver a different strategic goal, and is currently advancing a broad portfolio of therapeutic programs.
Key slides for Prime Medicine Inc
J.P. Morgan 42nd Annual Healthcare Conference 2024
Prime Medicine Inc
J.P. Morgan 42nd Annual Healthcare Conference 2024
Prime Medicine Inc
Latest articles
Four Decades of IPOs: An Overview
An overview of the stock and IPO market from the 80's until today, highlighting important events and trends.
24 Apr 2024
Larry Page: The Mastermind Behind Google
Explore the journey of Larry Page from a tech-savvy youth to co-founding Google and leading Alphabet.
24 Apr 2024
Mark Leonard: The Mysterious Brain Behind Constellation Software
Information about Mark Leonard is scarce, and one of the only ways to “get to know” him is through his shareholder letters. Join us in an attempt to do so.
24 Apr 2024
Ticker symbol
Country
🇺🇸 United States